Flow cytometry is a bio-physical, laser-based logical generation that measures and analyzes numerous physical characteristics of cells floating in a fluid, while surpassed via a laser beam. Flow cytometry has various benefits over traditional analytical strategies. Together with elisa, this incorporates its ability to deliver specific and correct outcomes, and lesser time consumption at approximately equal prices. The flow cytometry technology is broadly used in various fields of educational and medical studies. It diagnosis diseases such as HIV, cancers and hematological diseases.
The Global Flow Cytometry Market is segmented on the lines of its technology, component, application, end user and regional. Based on technology segmentation it covers bead based flow cytometry and cell based flow cytometry. Under component segmentation it covers instruments which further segmented into cytometry platforms, replaceable components, accessories, reagents and consumables, software and services. Based on application segmentation it covers academic and clinical research applications and diagnosis applications. Under end user it consists of commercial organizations, medical schools and clinical labs, hospitals, academics and others. The Global Flow Cytometry Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report includeDickinson and Company (NYSE:BDX), EMD Millipore, Sysmex Corporation, Affymetix Inc., Luminex Corporation (NASDAQ:LMNX), Thermo Fischer Scientific, Bio-Rad Laboratories (NYSE:BIO), Inc., MiltenyiBiotec, Inc., Agilent Technologies (NYSE:A), Inc. Danaher Corporation (Beckman Coulter) and Becton. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Find Full Report Here:https://www.marketresearchengine.com/flow-cytometry-market
The Global Flow Cytometry Market is expected to exceed more than US$ 5.50 Billion by 2024 at a CAGR of 9.5% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Global Flow Cytometry Market with the reasons given for variations in the growth of the industry in certain regions.
This report provides:
1) An overview of the global market for Flow Cytometry and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Flow Cytometry Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Global Flow Cytometry Market has been segmented as below:
The Global Flow Cytometry Market is Segmented on the lines of Technology Analysis, Component Analysis, Application Analysis, End User Analysis and Regional Analysis.By Technology Analysisthis market is segmented on the basis ofBead based flow cytometry and Cell based flow cytometry. By Component Analysisthis market is segmented on the basis ofInstruments its covers Cytometry platforms, Replaceable components, Accessories, Reagents and consumables, Software and Services.
By Application Analysisthis market is segmented on the basis ofAcademic and clinical research applications and Diagnosis applications. By End User Analysisthis market is segmented on the basis ofCommercial organizations sector, Medical schools and clinical labs sector, Hospitals sector, Academics sector and Others sectors. By Regional Analysisthis market is segmented on the basis ofNorth America, Europe, Asia-Pacific and Rest of the World.
The major driving factors of Global Flow Cytometry Market are as follows:
- Technical development in flow cytometers
- Increasing acceptance of flow cytometry method in research activities
- Rising use of flow cytometry in medical trials
- Increasing occurrence of HIV and cancer
- Developing economies offer growth opportunities
The restraining factors of Global Flow Cytometry Market are as follows:
- High rate of instruments
- Need awareness and technological Knowledge concerning the use of flow cytometers
- Emerging countries are not having proper infrastructure for research
- Reagent developments are complex
Request Sample Report:https://www.marketresearchengine.com/flow-cytometry-market
Table of Contents
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
188.8.131.52 Key Data From Secondary Sources
2.1.2 Primary Data
184.108.40.206 Breakdown of Primaries
220.127.116.11 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Flow Cytometry Market, By Technology
7 Global Flow Cytometry Market, By Products & Services
8 Global Flow Cytometry Market, By Application
9 Global Flow Cytometry Market, By End User
10 Global Flow Cytometry Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1.1 Geographic Benchmarking
12.2 Becton, Dickinson and Company
12.3 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
12.4 Thermo Fisher Scientific, Inc.
12.5 Merck KGAA
12.6 Bio-Rad Laboratories, Inc.
12.7 Affymetrix, Inc. (A Thermo Fisher Scientific, Inc. Company)
12.8 Miltenyi Biotec GmbH
12.9 Sysmex Partec GmbH (A Subsidiary of Sysmex Corporation)
12.10 Luminex Corporation
12.11 Sony Biotechnology Inc.
Other Related Market News:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States